annual operating expenses:
$1.36B+$3.98M(+0.29%)Summary
- As of today (June 20, 2025), SRPT annual total operating expenses is $1.36 billion, with the most recent change of +$3.98 million (+0.29%) on December 31, 2024.
- During the last 3 years, SRPT annual operating expenses has risen by +$310.25 million (+29.42%).
- SRPT annual operating expenses is now at all-time high.
Performance
SRPT Operating expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly operating expenses:
$907.68M+$543.25M(+149.07%)Summary
- As of today (June 20, 2025), SRPT quarterly total operating expenses is $907.68 million, with the most recent change of +$543.25 million (+149.07%) on March 1, 2025.
- Over the past year, SRPT quarterly operating expenses has increased by +$579.68 million (+176.73%).
- SRPT quarterly operating expenses is now at all-time high.
Performance
SRPT quarterly operating expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Operating expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
SRPT Operating expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +0.3% | +176.7% |
| 3 y3 years | +29.4% | +240.9% |
| 5 y5 years | +61.2% | +314.3% |
SRPT Operating expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +29.4% | at high | +240.9% |
| 5 y | 5-year | at high | +61.2% | at high | +352.9% |
| alltime | all time | at high | >+9999.0% | at high | >+9999.0% |
SRPT Operating expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $907.68M(+149.1%) |
| Dec 2024 | $1.36B(+0.3%) | $364.43M(+3.2%) |
| Sep 2024 | - | $353.29M(+10.7%) |
| Jun 2024 | - | $319.09M(-2.7%) |
| Mar 2024 | - | $328.00M(+0.0%) |
| Dec 2023 | $1.36B(+2.4%) | $327.98M(+3.9%) |
| Sep 2023 | - | $315.63M(-12.5%) |
| Jun 2023 | - | $360.63M(+1.1%) |
| Mar 2023 | - | $356.57M(+6.6%) |
| Dec 2022 | $1.33B(+26.0%) | $334.46M(+4.0%) |
| Sep 2022 | - | $321.67M(-20.9%) |
| Jun 2022 | - | $406.82M(+52.8%) |
| Mar 2022 | - | $266.27M(-3.4%) |
| Dec 2021 | $1.05B(+1.3%) | $275.53M(+37.5%) |
| Sep 2021 | - | $200.42M(-35.8%) |
| Jun 2021 | - | $312.15M(+17.2%) |
| Mar 2021 | - | $266.45M(-9.2%) |
| Dec 2020 | $1.04B(+23.0%) | $293.45M(+10.3%) |
| Sep 2020 | - | $265.98M(+1.4%) |
| Jun 2020 | - | $262.38M(+19.8%) |
| Mar 2020 | - | $219.08M(-28.1%) |
| Dec 2019 | $846.57M(+38.7%) | $304.76M(+45.4%) |
| Sep 2019 | - | $209.59M(+15.9%) |
| Jun 2019 | - | $180.88M(+19.5%) |
| Mar 2019 | - | $151.34M(-27.4%) |
| Dec 2018 | $610.47M(+110.2%) | $208.42M(+49.0%) |
| Sep 2018 | - | $139.84M(-18.9%) |
| Jun 2018 | - | $172.44M(+92.1%) |
| Mar 2018 | - | $89.76M(+13.0%) |
| Dec 2017 | $290.44M(+7.8%) | $79.47M(+25.7%) |
| Sep 2017 | - | $63.20M(-31.7%) |
| Jun 2017 | - | $92.58M(+67.2%) |
| Mar 2017 | - | $55.36M(-39.7%) |
| Dec 2016 | $269.50M(+21.7%) | $91.81M(+62.4%) |
| Sep 2016 | - | $56.53M(-8.8%) |
| Jun 2016 | - | $61.98M(+3.8%) |
| Mar 2016 | - | $59.70M(-9.1%) |
| Dec 2015 | $221.44M(+54.3%) | $65.70M(+26.9%) |
| Sep 2015 | - | $51.76M(+22.9%) |
| Jun 2015 | - | $42.11M(-31.9%) |
| Mar 2015 | - | $61.86M(+38.2%) |
| Dec 2014 | $143.55M(+37.4%) | $44.75M(+28.8%) |
| Sep 2014 | - | $34.73M(+5.7%) |
| Jun 2014 | - | $32.85M(+5.3%) |
| Mar 2014 | - | $31.21M(-12.0%) |
| Dec 2013 | $104.50M(+55.9%) | $35.48M(+21.9%) |
| Sep 2013 | - | $29.10M(+45.2%) |
| Jun 2013 | - | $20.04M(+0.7%) |
| Mar 2013 | - | $19.89M(+12.3%) |
| Dec 2012 | $67.03M(-19.2%) | $17.70M(+22.3%) |
| Sep 2012 | - | $14.48M(-13.6%) |
| Jun 2012 | - | $16.76M(-7.3%) |
| Mar 2012 | - | $18.09M(-19.9%) |
| Dec 2011 | $82.92M(+64.7%) | $22.59M(+20.2%) |
| Sep 2011 | - | $18.80M(-13.4%) |
| Jun 2011 | - | $21.71M(+9.5%) |
| Mar 2011 | - | $19.83M(+14.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2010 | $50.35M(+52.2%) | $17.26M(+38.1%) |
| Sep 2010 | - | $12.50M(+7.2%) |
| Jun 2010 | - | $11.66M(+30.5%) |
| Mar 2010 | - | $8.94M(-1.7%) |
| Dec 2009 | $33.09M(-14.7%) | $9.10M(-1.9%) |
| Sep 2009 | - | $9.27M(+15.8%) |
| Jun 2009 | - | $8.01M(+19.3%) |
| Mar 2009 | - | $6.71M(-19.8%) |
| Dec 2008 | $38.80M(-12.0%) | $8.37M(-24.6%) |
| Sep 2008 | - | $11.11M(+12.6%) |
| Jun 2008 | - | $9.86M(+4.3%) |
| Mar 2008 | - | $9.46M(-12.9%) |
| Dec 2007 | $44.09M(+33.2%) | $10.85M(-5.0%) |
| Sep 2007 | - | $11.43M(+2.1%) |
| Jun 2007 | - | $11.19M(+5.4%) |
| Mar 2007 | - | $10.62M(+20.8%) |
| Dec 2006 | $33.10M(+48.4%) | $8.79M(+20.6%) |
| Sep 2006 | - | $7.29M(-2.0%) |
| Jun 2006 | - | $7.44M(-22.4%) |
| Mar 2006 | - | $9.59M(+51.6%) |
| Dec 2005 | $22.30M(-12.5%) | $6.32M(+21.6%) |
| Sep 2005 | - | $5.20M(+0.2%) |
| Jun 2005 | - | $5.19M(-7.2%) |
| Mar 2005 | - | $5.59M(+7.0%) |
| Dec 2004 | $25.47M(+28.4%) | $5.22M(+1.8%) |
| Sep 2004 | - | $5.13M(-29.4%) |
| Jun 2004 | - | $7.27M(-7.4%) |
| Mar 2004 | - | $7.85M(+7.7%) |
| Dec 2003 | $19.84M(-24.2%) | $7.29M(+43.2%) |
| Sep 2003 | - | $5.09M(+37.1%) |
| Jun 2003 | - | $3.72M(-0.6%) |
| Mar 2003 | - | $3.74M(-13.5%) |
| Dec 2002 | $26.18M(+62.5%) | $4.32M(-22.9%) |
| Sep 2002 | - | $5.60M(-31.0%) |
| Jun 2002 | - | $8.12M(-0.2%) |
| Mar 2002 | - | $8.13M(+61.8%) |
| Dec 2001 | $16.11M(+34.7%) | $5.03M(+37.6%) |
| Sep 2001 | - | $3.65M(-5.7%) |
| Jun 2001 | - | $3.87M(+8.9%) |
| Mar 2001 | - | $3.56M(-2.8%) |
| Dec 2000 | $11.96M(+37.4%) | $3.66M(+30.7%) |
| Sep 2000 | - | $2.80M(-8.2%) |
| Jun 2000 | - | $3.05M(+24.7%) |
| Mar 2000 | - | $2.45M(-2.2%) |
| Dec 1999 | $8.70M(+7.4%) | $2.50M(+8.7%) |
| Sep 1999 | - | $2.30M(+15.0%) |
| Jun 1999 | - | $2.00M(+11.1%) |
| Mar 1999 | - | $1.80M(-30.8%) |
| Dec 1998 | $8.10M(+80.0%) | $2.60M(+30.0%) |
| Sep 1998 | - | $2.00M(+5.3%) |
| Jun 1998 | - | $1.90M(+11.8%) |
| Mar 1998 | - | $1.70M(+41.7%) |
| Dec 1997 | $4.50M(+60.7%) | $1.20M(+20.0%) |
| Sep 1997 | - | $1.00M(-33.3%) |
| Jun 1997 | - | $1.50M(+87.5%) |
| Mar 1997 | - | $800.00K |
| Dec 1996 | $2.80M | - |
FAQ
- What is Sarepta Therapeutics annual total operating expenses?
- What is the all time high annual operating expenses for Sarepta Therapeutics?
- What is Sarepta Therapeutics annual operating expenses year-on-year change?
- What is Sarepta Therapeutics quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Sarepta Therapeutics?
- What is Sarepta Therapeutics quarterly operating expenses year-on-year change?
What is Sarepta Therapeutics annual total operating expenses?
The current annual operating expenses of SRPT is $1.36B
What is the all time high annual operating expenses for Sarepta Therapeutics?
Sarepta Therapeutics all-time high annual total operating expenses is $1.36B
What is Sarepta Therapeutics annual operating expenses year-on-year change?
Over the past year, SRPT annual total operating expenses has changed by +$3.98M (+0.29%)
What is Sarepta Therapeutics quarterly total operating expenses?
The current quarterly operating expenses of SRPT is $907.68M
What is the all time high quarterly operating expenses for Sarepta Therapeutics?
Sarepta Therapeutics all-time high quarterly total operating expenses is $907.68M
What is Sarepta Therapeutics quarterly operating expenses year-on-year change?
Over the past year, SRPT quarterly total operating expenses has changed by +$579.68M (+176.73%)